Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium vesicular trafficking machinery is a specialized network of organelles, proteins, and lipids that the malaria parasite uses to survive and replicate within host red blood cells. This system is responsible for the synthesis, transport, and export of proteins across multiple membranes, including the parasite plasma membrane and the parasitophorous vacuole membrane (PVM). A central component is the Plasmodium translocon of exported proteins (PTEX), which acts as a gatekeeper for proteins destined for the host cell (Elsworth et al., 2014, Nature). These exported proteins are essential for remodeling the erythrocyte to facilitate nutrient uptake and for the presentation of virulence factors like PfEMP1 on the cell surface to evade the immune system (Koumandou et al., 2011, Molecular Microbiology). Drugs targeting this machinery, such as Ganaplacide (KAF156) and various PI3K/PI4K inhibitors, work by disrupting these transport processes, effectively starving the parasite or preventing it from modifying its environment (McNamara et al., 2013, Science). However, because many elements of this machinery are conserved across eukaryotes, achieving high selectivity for the parasite over the human host remains a significant therapeutic challenge (Langsley et al., 2008, Traffic).
Inhibition of protein export via the PTEX complex, disruption of phosphoinositide signaling (PI3K/PI4K), and interference with vesicle formation and fusion mediated by Rab GTPases and SNAREs.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium vesicular trafficking machinery.